Jackson Financial Inc.
For the period ended Jun 30, 2025. Filed Aug 5, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 5, 2025
JXN$138.01+1.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
| Six Months Ended June 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Cash flows from operating activities: | ||
| Net income (loss) | $167 | $1,084 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Net realized losses (gains) on investments | 175 | 37 |
| Net losses (gains) on derivatives | 1,342 | 4,197 |
| Net losses (gains) on funds withheld reinsurance treaties | 715 | 415 |
| Net (gain) loss on market risk benefits | 43 | (3,234) |
| (Gain) loss from updating future policy benefits cash flow assumptions, net | 24 | (7) |
| Interest credited on other contract holder funds, gross | 583 | 546 |
| Mortality, expense and surrender charges | (263) | (272) |
| Amortization of discount and premium on investments | (18) | (28) |
| Deferred income tax expense (benefit) | (7) | (30) |
| Share-based compensation | 72 | 93 |
| Change in: | ||
| Accrued investment income | (32) | (6) |
| Deferred acquisition costs | 206 | 236 |
| Funds withheld, net of reinsurance | 168 | 202 |
| Future policy benefits | (277) | (368) |
| Other assets and liabilities, net | (131) | 39 |
| Net cash provided by (used in) operating activities | 2,767 | 2,904 |
| Cash flows from investing activities: | ||
| Sales, maturities and repayments of: | ||
| Debt securities | 4,091 | 5,259 |
| Equity securities | 19 | 193 |
| Mortgage loans | 730 | 767 |
| Purchases of: | ||
| Debt securities | (6,758) | (5,940) |
| Equity securities | — | (5) |
| Mortgage loans | (751) | (333) |
| Settlements related to derivatives and collateral on investments | (928) | (3,468) |
| Other investing activities | (121) | (393) |
| Net cash provided by (used in) investing activities | (3,718) | (3,920) |
(continued)
Condensed Consolidated Statements of Cash Flows (continued)
| Six Months Ended June 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Cash flows from financing activities: | ||
| Policyholders' account balances: | ||
| Deposits | $12,126 | $8,760 |
| Withdrawals | (19,353) | (19,209) |
| Net transfers from (to) separate accounts | 9,465 | 8,744 |
| Proceeds from (payments on) repurchase agreements and securities lending | (383) | 1,776 |
| Net proceeds from (payments on) Federal Home Loan Bank notes | (700) | 250 |
| Payments on debt | (4) | (4) |
| Issuance of debt of consolidated investment entities | 395 | 481 |
| Repayments of debt of consolidated investment entities | (98) | (399) |
| Contributions from partners of consolidated investments | 17 | 23 |
| Dividends on common stock | (115) | (107) |
| Dividends on preferred stock | (22) | (22) |
| Purchase of treasury stock | (360) | (229) |
| Net cash provided by (used in) financing activities | 968 | 64 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 17 | (952) |
| Cash, cash equivalents, and restricted cash at beginning of period | 3,767 | 2,691 |
| Total cash, cash equivalents, and restricted cash at end of period | $3,784 | $1,739 |
| Supplemental cash flow information | ||
| Income taxes paid (received) | $(11) | $157 |
| Interest paid | $127 | $135 |
| Non-cash investing activities | ||
| Debt securities acquired from exchanges, payments-in-kind, and similar transactions | $178 | $36 |
| Non-cash financing activities | ||
| Non-cash dividend equivalents on stock-based awards | $(2) | $(3) |
| Reconciliation to Condensed Consolidated Balance Sheets | ||
| Cash and cash equivalents | $3,784 | $1,736 |
| Restricted cash (included in Other assets) | — | 3 |
| Total cash, cash equivalents, and restricted cash | $3,784 | $1,739 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.